We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.3B
AUM Growth
+$273M
(+13%)
Cap. Flow
+$241M
Cap. Flow
% of AUM
10.48%
Top 10 Holdings %
Top 10 Hldgs %
43.45%
Holding
86
New
20
Increased
27
Reduced
19
Closed
15
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$73.7M |
| 2 |
Abbott
ABT
|
+$49.7M |
| 3 |
BLUE
bluebird bio
BLUE
|
+$40.7M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$37.3M |
| 5 |
Teleflex
TFX
|
+$35.5M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$40.2M |
| 2 |
AET
Aetna Inc
AET
|
+$37.2M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$34.4M |
| 4 |
Molina Healthcare
MOH
|
+$31.7M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$28.7M |
Sector Composition
| 1 | Healthcare | 92.78% |
| 2 | Financials | 1.18% |
| 3 | Communication Services | 0.58% |
| 4 | Technology | 0.01% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $245M | 10.64% |
19,113,864
+1,557,278
| +9% | +$17.7M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $144M | 6.27% |
10,025,770
-986,791
| -9% | -$13.6M |
|
3
Puma Biotechnology
PBYI
$432M
| $90.3M | 3.93% |
913,573
+6,931
| +0.8% | +$776K |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $89.8M | 3.9% |
1,320,027
+323,417
| +32% | +$22.6M |
|
5
Wave Life Sciences
WVE
$1.15B
| $77.5M | 3.37% |
2,209,107
-58,600
| -3% | -$1.71M |
|
|
ALDR
6
DELISTED
Alder Biopharmaceuticals
ALDR
| $74.5M | 3.24% |
6,505,766
+29,000
| +0.4% | +$324K |
|
7
AstraZeneca
AZN
$261B
| $70.2M | 3.05% |
1,010,800
-112,350
| -10% | -$7.58M |
|
8
Insmed
INSM
$23.8B
| $70.1M | 3.05% |
2,249,262
+257,616
| +13% | +$7.61M |
|
|
IMGN
9
DELISTED
Immunogen Inc
IMGN
| $69.9M | 3.04% |
10,906,962
+2,845,465
| +35% | +$17.5M |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $68.1M | 2.96% |
+653,000
| New | +$73.7M |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $61.8M | 2.69% |
1,156,021
-687,712
| -37% | -$40.2M |
|
12
Penumbra
PEN
$12.5B
| $58.1M | 2.53% |
617,279
+51,768
| +9% | +$5.13M |
|
13
Centene
CNC
$32.8B
| $54.6M | 2.37% |
1,083,000
+273,800
| +34% | +$13.3M |
|
|
14
Abbott
ABT
$154B
| $51.2M | 2.23% |
+896,900
| New | +$49.7M |
|
15
Atara Biotherapeutics
ATRA
$76.1M
| $51M | 2.22% |
112,640
-2,948
| -3% | -$1.09M |
|
16
LivaNova
LIVN
$4.37B
| $49.2M | 2.14% |
615,588
-16,900
| -3% | -$1.34M |
|
17
Regenxbio
RGNX
$637M
| $47.4M | 2.06% |
1,425,272
-242,400
| -15% | -$7.3M |
|
|
SYNH
18
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $46.5M | 2.02% |
1,067,318
+799,400
| +298% | +$37.3M |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $46.3M | 2.01% |
+20,057
| New | +$40.7M |
|
20
iRhythm Holdings
IRTC
$3.74B
| $45.7M | 1.98% |
814,574
+262,533
| +48% | +$13.7M |
|
|
21
Teleflex
TFX
$5.81B
| $42.9M | 1.87% |
172,486
+141,121
| +450% | +$35.5M |
|
|
CTLT
22
DELISTED
CATALENT, INC.
CTLT
| $34.2M | 1.49% |
833,063
+685,400
| +464% | +$27.9M |
|
23
Fate Therapeutics
FATE
$350M
| $33.4M | 1.45% |
5,465,486
+4,046,428
| +285% | +$18.1M |
|
24
UnitedHealth
UNH
$380B
| $32.8M | 1.42% |
148,620
+146,800
| +8,066% | +$31.1M |
|
|
CBIO
25
Crescent Biopharma
CBIO
$424M
| $32.4M | 1.41% |
19,307
+7,166
| +59% | +$9.48M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO